
IndraLab
Statements
Tetracycline inhibits CASP1. 9 / 9
|
9
reach
"In summary, current study suggests that tetracycline inhibits caspase-1 activation in response to silica and ameliorates silica-induced pulmonary inflammation including IL-1ß production, thereby reducing lung injury and fibrotic lung remodeling.Tetracycline reduced caspase-1-dependent production of IL-1β in response to silica in vitro and in vivo."
reach
"These results indicate that tetracycline selectively blocks silicainduced IL-1ß production and pyroptosis of BMDM.Since tetracycline decreased both silica-induced IL-1ß production and pyroptosis, we conducted immunoblot analysis to examine whether tetracycline inhibits caspase-1 activation in BMDM in response to silica."
reach
"To bring these findings back to the bedside, they reexamined the subtype of patients with ARDS that were identified earlier and were able to confirm that tetracycline would limit caspase 1 activity of pulmonary leukocytes.The combination of precision medicine and translation from bed to bench and back is novel to ARDS research and is the major strength of the study."